Redundant trials in China lead to more MACEs, deaths in control participants
10 Feb 2021
bởiStephen Padilla
More than 2,000 redundant clinical trials on statins in patients with coronary artery disease (CAD) have been identified from mainland China, resulting in an extra 3,000 major adverse cardiac events (MACEs), including nearly 600 deaths, among participants who were not treated with statins in these trials, according to a cross-sectional study.
